These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31598611)

  • 41. Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.
    Minniti E; Byl JAW; Riccardi L; Sissi C; Rosini M; De Vivo M; Minarini A; Osheroff N
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4687-4693. PubMed ID: 28919339
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of cellular ATP depletion on topoisomerase II poisons. Abrogation Of cleavable-complex formation by etoposide but not by amsacrine.
    Sorensen M; Sehested M; Jensen PB
    Mol Pharmacol; 1999 Mar; 55(3):424-31. PubMed ID: 10051525
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint.
    Kozuki T; Chikamori K; Surleac MD; Micluta MA; Petrescu AJ; Norris EJ; Elson P; Hoeltge GA; Grabowski DR; Porter ACG; Ganapathi RN; Ganapathi MK
    Nucleic Acids Res; 2017 Jun; 45(10):5995-6010. PubMed ID: 28472494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biophysical and molecular docking studies of naphthoquinone derivatives on the ATPase domain of human topoisomerase II.
    Boonyalai N; Sittikul P; Pradidphol N; Kongkathip N
    Biomed Pharmacother; 2013 Mar; 67(2):122-8. PubMed ID: 23089478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recovery of the poisoned topoisomerase II for DNA religation: coordinated motion of the cleavage core revealed with the microsecond atomistic simulation.
    Huang NL; Lin JH
    Nucleic Acids Res; 2015 Aug; 43(14):6772-86. PubMed ID: 26150421
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Emodin triggers DNA double-strand breaks by stabilizing topoisomerase II-DNA cleavage complexes and by inhibiting ATP hydrolysis of topoisomerase II.
    Li Y; Luan Y; Qi X; Li M; Gong L; Xue X; Wu X; Wu Y; Chen M; Xing G; Yao J; Ren J
    Toxicol Sci; 2010 Dec; 118(2):435-43. PubMed ID: 20855424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Monocyclic 4-amino-6-(phenylamino)-1,3,5-triazines as inhibitors of human DNA topoisomerase IIα.
    Pogorelčnik B; Brvar M; Zajc I; Filipič M; Solmajer T; Perdih A
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5762-5768. PubMed ID: 25453816
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha.
    Patel S; Jazrawi E; Creighton AM; Austin CA; Fisher LM
    Mol Pharmacol; 2000 Sep; 58(3):560-8. PubMed ID: 10953049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential immunohistochemical staining for DNA topoisomerase II alpha and beta in human tissues and for DNA topoisomerase II beta in non-Hodgkin's lymphomas.
    Bauman ME; Holden JA; Brown KA; Harker WG; Perkins SL
    Mod Pathol; 1997 Mar; 10(3):168-75. PubMed ID: 9071722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors.
    Tabrizi MA; Baraldi PG; Baraldi S; Prencipe F; Preti D; Saponaro G; Romagnoli R; Gessi S; Merighi S; Stefanelli A; Fazzi D; Borea PA; Maia RC; Romeiro NC; Fraga CA; Barreiro EJ
    Med Chem; 2015; 11(4):342-53. PubMed ID: 25494808
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resveratrol: A novel type of topoisomerase II inhibitor.
    Lee JH; Wendorff TJ; Berger JM
    J Biol Chem; 2017 Dec; 292(51):21011-21022. PubMed ID: 29074616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase.
    Baviskar AT; Madaan C; Preet R; Mohapatra P; Jain V; Agarwal A; Guchhait SK; Kundu CN; Banerjee UC; Bharatam PV
    J Med Chem; 2011 Jul; 54(14):5013-30. PubMed ID: 21644529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism of action of ferrocene derivatives on the catalytic activity of topoisomerase IIalpha and beta--distinct mode of action of two derivatives.
    Sai Krishna AD; Panda G; Kondapi AK
    Arch Biochem Biophys; 2005 Jun; 438(2):206-16. PubMed ID: 15907782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Etoposide targets topoisomerase IIalpha and IIbeta in leukemic cells: isoform-specific cleavable complexes visualized and quantified in situ by a novel immunofluorescence technique.
    Willmore E; Frank AJ; Padget K; Tilby MJ; Austin CA
    Mol Pharmacol; 1998 Jul; 54(1):78-85. PubMed ID: 9658192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel peroxisome proliferator-activated receptor alpha/gamma agonist, BPR1H0101, inhibits topoisomerase II catalytic activity in human cancer cells.
    Kao YH; Hsieh HP; Chitlimalla SK; Pan WY; Kuo CC; Tsai YC; Lin WH; Chuang SE; Chang JY
    Anticancer Drugs; 2008 Feb; 19(2):151-8. PubMed ID: 18176111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of 4β-carbamoyl epipodophyllotoxins as potential antitumour agents.
    Kamal A; Kumar BA; Suresh P; Juvekar A; Zingde S
    Bioorg Med Chem; 2011 May; 19(9):2975-9. PubMed ID: 21489802
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel 2-aryl-4-(4'-hydroxyphenyl)-5H-indeno[1,2-b]pyridines as potent DNA non-intercalative topoisomerase catalytic inhibitors.
    Park S; Kadayat TM; Jun KY; Thapa Magar TB; Bist G; Shrestha A; Lee ES; Kwon Y
    Eur J Med Chem; 2017 Jan; 125():14-28. PubMed ID: 27643560
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential Targeting of Human Topoisomerase II Isoforms with Small Molecules.
    Mariani A; Bartoli A; Atwal M; Lee KC; Austin CA; Rodriguez R
    J Med Chem; 2015 Jun; 58(11):4851-6. PubMed ID: 25945730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutation of cysteine residue 455 to alanine in human topoisomerase IIalpha confers hypersensitivity to quinones: enhancing DNA scission by closing the N-terminal protein gate.
    Bender RP; Osheroff N
    Chem Res Toxicol; 2007 Jun; 20(6):975-81. PubMed ID: 17516663
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.
    Yao BL; Mai YW; Chen SB; Xie HT; Yao PF; Ou TM; Tan JH; Wang HG; Li D; Huang SL; Gu LQ; Huang ZS
    Eur J Med Chem; 2015 Mar; 92():540-53. PubMed ID: 25599951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.